Indian Immunologicals targets dengue vaccine launch by January 2026Vaccine manufacturer Indian Immunologicals Limited (IIL) expects to commercially launch its dengue fever vaccine by early 2026, a top execu...
IIL gets regulatory nod for measles-rubella vaccineThe MR vaccine was developed by Hyderabad-based IIL in exclusive partnership with Vietnam's state owned Center for Research and Production ...
PSU vaccine maker IIL to invest Rs 700 crore on new facility in HyderabadThe proposed facility will be making Foot and Mouth disease (FMD) and other emerging diseases. The facility will create total employment fo...
Insecticides India gets GSP compliance certification for its Chopanki R&D labIIL managing director Rajesh Aggarwal said, "We are adding another feather to its cap, Insecticides (India) Limited (IIL), the country’s le...
IIL to make 10 million doses of Covaxin drug substance from DecemberIndian Immunologicals' Managing Director K Anand Kumar informed that IIL is also working on an attenuated COVID-19 vaccine which is likely ...
Indian Immunologiclas to start drug substance production for Covaxin from JuneManaging Director K Anand Kumar in a release on Friday said the firm is expected to produce the drug substance initially for 2-3 million do...
Bharat Biotech ties up with IIL for Covaxin materialHyderabad-based IIL, part of the NDDB, said it will send out the first batch of the drug ingredient to Bharat Biotech by July.
Hyderabad company, Australian varsity partner for vaccineScientists from India and Australia will develop a ‘live attenuated SARS – CoV-2 vaccine’ using the latest codon deoptimisation technology,...
Insecticides India gets green nod for Rs 40 cr pesticide unit in GujaratThe clearance, however, has been given with some conditions, the document added. As per the proposal, IIL wants to set up a pesticide and p...
NDDB-arm develops world’s first vaccine against tapeworms in pigsIIL has obtained the license the to manufacture and market the vaccine after conducting extensive field trials in India and many other coun...
IIL opens 'New Bovine Serum' manufacturing unit in New ZealandBiologicals company Indian Immunologicals Limited (IIL) today inaugurated its 'New Bovine Serum' manufacturing plant in New Zealand.
'Indian Immunologicals Ltd capable of delivering 360 mn doses/yr of Foot and Mouth disease vaccines'NDDB chairman T Nanda also inaugurated IIL's new FMD vaccine manufacturing block at its Gachibowli vaccine complex here.
IIL's Rs 40-crore R&D facility becomes operationalThe research and development (R&D) facility is set up by OAT and IIL Laboratories Ltd, a joint venture company between IIL and Japanese fir...
- Crisil maintains the fundamental grade of 3/5 for Insecticides India Ltd
Crisil maintains the fundamental grade of 3/5 for Insecticides India Ltd, indicating that its fundamentals are good relative to other liste...
- IIL to launch Japanese product, ropes in Suniel Shetty
IIL, an agro chemicals manufacturing company launched PULSOR, a new generation fungicide from its partner Japanese Company Nissan Chemical ...
- E*Trade buys 4.5% in IL&FS co from Fidelity for Rs 63cr
Even before E*Trade’s public offer for a 20% stake in IL&FS Investsmart (IIL) hits the market, the US-based on-line broking giant has firme...
- Ispat plans for pellet plant at Vizag
Ispat Industries Ltd, (IIL) has decided to sponsor a special purpose vehicle to set up a three million tonne iron ore pellet plant in Visak...